Home
Organic reaction
Organic synthesis
Peptide synthesis
Patent Highlights
►Pfizer
►Roche
WO2010020548
WO2010026110
WO2010043515
WO2010043513
WO2010018112
WO2010018113
WO2010026075
WO2010046273
WO2010028981
WO2010031708
WO2010031713
WO2010034649
WO2010034656
WO2010034657
WO2010034671
WO2010040661
WO2010040663
WO2010049303
WO2010049331
WO2010054961
WO2010054968
WO2010055004
WO2010055005
WO2010055006
WO2010030703
WO2010057795
WO2010063610
WO2010063634
WO2010031707
►Merck
►Galapagos
►Astrazeneca
►GSK
►Novartis
►Sanofi-aventis
►Janssen
►Amgen
Synthetic protocols
Organic and Medicinal Chemistry News
Pharmaceuticals Patents News
Universities and Institutes Patents News
Contact
WO2010054961 Spiro-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulenes
WO2010054961.pdf
Adobe Acrobat Document
3.1 MB
Download
Biological target:
Vasopressin:
V1a
Activity:
antagonist
Site Search